ANTI-IL-13 ANTIBODY FORMULATION

The present invention relates to a pharmaceutical composition comprising an anti-IL-13 antibody or an IL-13-binding fragment thereof, wherein the pharmaceutical composition comprises histidine buffer, a positively charged-excipient (e.g. lysine or arginine) and a surfactant. Such pharmaceutical comp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Choudhary, Sureshkumar Bhanaram, SAMADANI, Ramin
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a pharmaceutical composition comprising an anti-IL-13 antibody or an IL-13-binding fragment thereof, wherein the pharmaceutical composition comprises histidine buffer, a positively charged-excipient (e.g. lysine or arginine) and a surfactant. Such pharmaceutical compositions may be used for treating an IL-13 related disorder, such as atopic dermatitis, asthma, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease or Hodgkin's lymphoma.